泰山石化(01192.HK):訴訟項下經營實體的所有仲裁請求均被仲裁庭駁回
格隆匯11月13日丨泰山石化(01192.HK)發佈公告,有關成立特別調查委員會的目的是調查經營實體的違規情況,成立特別調查委員會後,隨着董事會成員的變動,特別調查委員會目前由三名成員組成,即黎頴麟(主席兼非執行董事)、劉斐(獨立非執行董事)及孫峯(獨立非執行董事)。
德恆已採取法律行動扞衞自己的立場,並對經營實體的前所有人提出反訴。基於上海國際經濟貿易仲裁委員會(上海國際仲裁中心)於2019年11月9日做出的仲裁裁決,該訴訟項下經營實體的前所有人作出的所有仲裁請求均被仲裁庭駁回。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.